HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hirokazu Urushiyama Selected Research

Isogeneic Transplantation

11/2021TGF-β-mediated epithelial-mesenchymal transition and tumor-promoting effects in CMT64 cells are reflected in the transcriptomic signature of human lung adenocarcinoma.
10/2020ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hirokazu Urushiyama Research Topics

Disease

8Neoplasms (Cancer)
11/2021 - 09/2013
4Idiopathic Pulmonary Fibrosis
03/2022 - 08/2015
4Lung Neoplasms (Lung Cancer)
11/2021 - 01/2018
4Fibrosis (Cirrhosis)
01/2020 - 10/2011
3Interstitial Lung Diseases (Interstitial Lung Disease)
12/2021 - 10/2019
3Inflammation (Inflammations)
01/2020 - 01/2019
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2022 - 09/2017
2Idiopathic Interstitial Pneumonias
11/2021 - 08/2015
2Asthma (Bronchial Asthma)
01/2021 - 01/2018
2Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 01/2019
2Adenocarcinoma of Lung
10/2020 - 02/2018
2Necrosis
10/2019 - 09/2013
2Hyperplasia
01/2019 - 10/2008
1Hemorrhage
03/2022
1Transfusion-Related Acute Lung Injury
07/2021
1Carcinogenesis
10/2020
1Airway Remodeling
01/2020
1Arthritis (Polyarthritis)
10/2019
1Constipation
01/2019
1Lung Injury
01/2019
1Dyslipidemias (Dyslipidemia)
01/2019
1Lung Diseases (Lung Disease)
01/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2018
1Diarrhea
08/2018
1Pain (Aches)
02/2018
1Thrombosis (Thrombus)
02/2018
1Lymphatic Metastasis
09/2017
1Histiocytosis
01/2017
1Organizing Pneumonia
08/2015
1Acute Lung Injury
10/2013
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
09/2013
1Carcinoma (Carcinomatosis)
09/2013
1Lymphadenopathy
11/2010
1Sarcoidosis (Schaumann Disease)
11/2010
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
07/2009
1Fever (Fevers)
07/2009
1Cough
07/2009

Drug/Important Bio-Agent (IBA)

3Cisplatin (Platino)FDA LinkGeneric
10/2018 - 01/2018
2ChemokinesIBA
10/2020 - 01/2019
2CollagenIBA
10/2019 - 08/2015
2Bleomycin (Blenoxane)FDA LinkGeneric
01/2019 - 01/2017
1MicroRNAs (MicroRNA)IBA
11/2022
1ThrombomodulinIBA
03/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2021
1Pharmaceutical PreparationsIBA
12/2021
1Transcription Factors (Transcription Factor)IBA
11/2021
1pirfenidoneIBA
01/2021
1PapainIBA
01/2021
1RNA (Ribonucleic Acid)IBA
10/2020
1CyclinsIBA
10/2020
1LipopolysaccharidesIBA
01/2020
1Interleukin-6 (Interleukin 6)IBA
10/2019
1Anti-Citrullinated Protein AntibodiesIBA
10/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2019
1Interleukin-13IBA
01/2019
1Bronchodilator Agents (Bronchodilators)IBA
01/2019
1TOR Serine-Threonine KinasesIBA
01/2019
1naftopidilIBA
01/2019
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2019
1indium-bleomycinIBA
01/2019
1Therapeutic UsesIBA
01/2019
1Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
01/2019
1LipidsIBA
01/2019
1Cholinergic Antagonists (Anticholinergics)IBA
01/2019
1PhenoxybenzamineFDA Link
01/2019
1Adrenergic Receptors (Adrenergic Receptor)IBA
01/2019
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2019
1Surface-Active Agents (Surfactants)IBA
01/2019
112,13- dihydro- N- methyl- 6,11,13- trioxo- 5H- benzo(4,5)cyclohepta(1,2- b)naphthalen- 5,12- imineIBA
01/2019
1Fluorouracil (Carac)FDA LinkGeneric
10/2018
1Vinorelbine (Navelbine)FDA LinkGeneric
10/2018
1hange-shashintoIBA
08/2018
1Irinotecan (Camptosar)FDA LinkGeneric
08/2018
1PeriostinIBA
01/2018
1PlatinumIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Carboplatin (JM8)FDA LinkGeneric
01/2018
1nedaplatinIBA
01/2018
1vinyltriethoxysilane (VTES)IBA
01/2018
1Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2017
1Collagen Type IV (Type IV Collagen)IBA
08/2015
1SurvivinIBA
10/2013
110-methyl spiro(4.5)dec-6-en-6-carboxylic acidIBA
09/2013
1Androgen Receptors (Androgen Receptor)IBA
09/2013
1Proteins (Proteins, Gene)FDA Link
09/2013
1MucinsIBA
09/2013
1Collagen Type III (Type III Collagen)IBA
10/2011
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
11/2010
1GalliumIBA
11/2010
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2009

Therapy/Procedure

3Therapeutics
12/2021 - 01/2019
3Adjuvant Chemotherapy
10/2018 - 09/2017
2Isogeneic Transplantation
11/2021 - 10/2020
2Lung Transplantation
11/2021 - 01/2020
2Drug Therapy (Chemotherapy)
02/2018 - 01/2018
1Length of Stay
03/2022
1Transplantation
11/2021
1Blood Transfusion (Blood Transfusions)
07/2021
1Kampo Medicine (Kampo)
01/2019
1Chemoradiotherapy
09/2017